DMRA financials
Damora Therapeutics (DMRA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DMRA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$210.87M | -$209.84M | 3.98 |
| 2024 | – | – | -$22.26M | -$21.44M | -18.53 |
| 2023 | – | – | -$39.91M | -$38.35M | -36.08 |
| 2022 | – | – | -$61.21M | -$61.62M | -60.75 |
| 2021 | – | – | -$52.23M | -$51.75M | -51.25 |
| 2020 | – | – | -$33.64M | -$34.84M | -190.50 |